Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
F-18-FDG Uptake at Initial Staging of the Adrenocortical Cancers: A Diagnostic Tool but Not of Prognostic Value
F-18-FDG PET and F-18-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
F-18-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas
F-18-FDG PET/CT findings of sinonasal inverted papilloma with or without coexistent malignancy: comparison with MR imaging findings in eight patients
F-18-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study
F-18-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors
F-18-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival
F-18-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors
F-18-FDG PET of the hands with a dedicated high-resolution PEM system (arthro-PET): correlation with PET/CT, radiography and clinical parameters
F-18-FDOPA PET/CT imaging of insulinoma revisited
F-18-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma
F-18 FDG PET/CT of Polymyalgia Rheumatica
F-18 FDG PET/CT Imaging in Small Cell Prostate Cancer
F-18-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients
F-18-FDG PET/CT Qualitative and Quantitative Evaluation in Neurofibromatosis Type 1 Patients for Detection of Malignant Transformation: Comparison of Early to Delayed Imaging With and Without Liver Activity Normalization
F-18-FAMT in patients with multiple myeloma: clinical utility compared to F-18-FDG
F-18-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation
F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma
F-18-labeled BBN-RGD heterodimer for prostate cancer imaging
F-18-FDG PET/CT as a Sensitive and Early Treatment Monitoring Tool: Will This Become the Major Thrust for Its Clinical Application in Infectious and Inflammatory Disorders? REPLY
F-18-FDG PET/CT as a predictor of hereditary head and neck paragangliomas
F-18 FDG PET/CT Findings in Two Patients With Pyothorax-Associated Lymphoma
F-18-FDG-PET/CT for rare aortic diseases: a sensible diagnostic alternative
F-18-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters
F-18 FDG PET/CT Imaging of Bulky Myxofibrosarcoma in Chest Wall
F-18 FDG Uptake in Hemorrhoids in a Patient With Diffuse Large B-cell Lymphoma
F-18 FDG PET/CT in the evaluation of Takayasu arteritis: An experience from the tropics
F-18-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
F-18-FDG PET Scanning in Pulmonary Amyloidosis
F-18-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities
F-18-FDG PET Detection of Unknown Primary Malignancy in Dermatomyositis
F-18-FDG PET/CT Demonstrating Primary Bone Lymphoma of the Extremities Mimicking an Inflammatory Peripheral Arthropathy
F-18-FDG PET/CT impact on testicular tumours clinical management
F-18-FDG PET/CT imaging of an anti-CTLA-4 antibody-associated autoimmune pancolitis
F-18-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations
F-18-fluordesoxiglucose positron emission tomography/computed tomography and unknown origin primary tumor. Current usefulness and future perspectives
F-18-Labeled benzylideneaniline derivatives as new ligands for beta-amyloid plaque imaging in Alzheimer's disease
F-18 Stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain
F-18-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis
F-18 fluorodeoxyglucose PET angiography of the abdominal arteries: evaluation of image quality and comparison with contrast-enhanced CT
F-18 Choline PET angiography of the pelvic arteries: evaluation of image quality and comparison with contrast-enhanced CT
F-18-FEAnGA for PET of beta-Glucuronidase Activity in Neuroinflammation
F-18-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis
F-18-Fluorodeoxyglucose Positron Emission Tomography/CT Scanning in Diagnosing Vascular Prosthetic Graft Infection
F-18-FDG-PET/CT Imaging in Patients with Febrile Neutropenia and Haematological Malignancies
F-18-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis
F-18-FDG uptake in small bowel intussusception in a patient of Langerhans cell histiocytosis and its resolution following successful conservative medical management
F-18-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study
F-18 FDG PET/CT Detecting Thyroid Plasmacytoma After the Successful Treatment of Gastric Large B-Cell Lymphoma
F-18-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
F-18-FDG Uptake Changes in Liver and Mediastinum During Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
F-18-FDG PET-derived parameters as prognostic indices in hepatic malignancies after Y-90 radioembolization: is there a role?
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors